Correlates of hepatitis C testing among heroin injectors in Sydney

Health Promotion Journal of Australia

Volumn 17, Issue 1, 2006, Pages 70-72

  Day, Carolyn ^a   Dolan, Kate ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatitis C; Injecting drug use; Testing

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; DEMOGRAPHY; DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; MALE; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE;

ADULT; AUSTRALIA; DEMOGRAPHY; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; MALE; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33745747267     PISSN: 10361073     EISSN: None     Source Type: Journal    
DOI: 10.1071/he06070     Document Type: Article

References (19)

1. MacDonald M, Law M, et al. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int J Drug Policy. 2003;14(5-6):353-7.
2. Dore G, Law M, MacDonald M, et al. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171-84.
3. Law M, Dore G, Bath N, Thompson S, Crofts N, Dolan K, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol. 2003;32:717-24.
4. MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Med J Aust. 2000;172:57-61.
5. Crofts N, Aitken C. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust. 1997;167:17-20.
6. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 2002;97(10):1289-94.
7. Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS. 1998;12:919-29.
8. Weinhardt LS, Carey MP Johnson BT, Bickham NL. Effects of HIV counselling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89(9):1397-405.
9. Aitken CK, Kerger M, Crofts N. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug Alcohol Rev. 2002;21(1):33-7.
10. Downing M, Knight K, Reiss TH, Vernon K, Mulia N, Ferreboeuf M, et al. Drug users talk about HIV testing: motivating and deterring factors. AIDS Care. 2001;13(5):561-77.
11. Jaeckel E, Comberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of Acute Hepatitis C with Interferon Alpha-2b. N Engl J Med. 2001;345(20):1452-7.
12. Nomura H, Sou S, Tanimoto H, Nagahama T, Kimura Y, Hayashi J, et al. Short-term Interferon-alpha therapy for acute hepatitis C: a randomized controlled trial. Hepatology. 2004;39:1213-19.
13. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2003, Sydney (AUST): National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2003.
14. Liebman J, Brooks D, Bonilla L, Kotranski L. Utilization of HIV antibody testing by out-of-treatment drug users. J Drug Issues. 1996;26(4):679-93.
15. Australian Bureau of Statistics. National Health Survey 1995. First results. Canberra (AUST): ABS; 1996.
16. Dolan K. Surveillance and Prevention of Hepatitis C Infection in Australian Prisons: A Discussion Paper. Canberra (AUST): National Drug and Alcohol Research Centre; 2000. Technical Report No.: 95.
17. Corben S. NSW Inmate Census 2000: Summary of Characteristics. Sydney (AUST): NSW Department of Corrective Services; 2001. Statistical Publication No.: 22.
18. Rutter S, Dolan K, Wodak A. Sex, Drugs and Viruses in Sin City Sydney, 1994. Sydney (AUST): National Drug and Alcohol Research Centre, University of New South Wales; 1996. Technical Report No.: 37.
19. Best D, Harris J, Gossop M, Farrell M, Finch E, Noble A, et al. Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug Alcohol Rev. 2000;19:9-16.